MX347911B - Vacuna contra virus de diarrea viral de bovinos. - Google Patents

Vacuna contra virus de diarrea viral de bovinos.

Info

Publication number
MX347911B
MX347911B MX2013003245A MX2013003245A MX347911B MX 347911 B MX347911 B MX 347911B MX 2013003245 A MX2013003245 A MX 2013003245A MX 2013003245 A MX2013003245 A MX 2013003245A MX 347911 B MX347911 B MX 347911B
Authority
MX
Mexico
Prior art keywords
vaccines
bvdv vaccine
virus
bvdv
vaccine
Prior art date
Application number
MX2013003245A
Other languages
English (en)
Other versions
MX2013003245A (es
Inventor
Martin Beer
Ilona Reimann
Patricia Koenig
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2013003245A publication Critical patent/MX2013003245A/es
Publication of MX347911B publication Critical patent/MX347911B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24362—Methods of inactivation or attenuation by genetic engineering

Abstract

La presente invención se refiere a virus de BVD y a sus usos, a vacunas y vacunas de combinación que comprenden dicho virus, su uso como un medicamento, su uso en el tratamiento de diarrea viral de bovino y a métodos para la preparación de dichas vacunas.
MX2013003245A 2010-09-21 2011-09-21 Vacuna contra virus de diarrea viral de bovinos. MX347911B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38501010P 2010-09-21 2010-09-21
EP10177931 2010-09-21
PCT/EP2011/066377 WO2012038454A1 (en) 2010-09-21 2011-09-21 Bvdv vaccine

Publications (2)

Publication Number Publication Date
MX2013003245A MX2013003245A (es) 2013-05-22
MX347911B true MX347911B (es) 2017-05-17

Family

ID=43110616

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013003245A MX347911B (es) 2010-09-21 2011-09-21 Vacuna contra virus de diarrea viral de bovinos.

Country Status (11)

Country Link
US (1) US9878030B2 (es)
EP (1) EP2618841B1 (es)
CN (1) CN103338785B (es)
AU (1) AU2011306957C1 (es)
BR (1) BR112013006515B1 (es)
CA (1) CA2811243C (es)
ES (1) ES2606605T3 (es)
MX (1) MX347911B (es)
RU (1) RU2578943C2 (es)
WO (1) WO2012038454A1 (es)
ZA (1) ZA201301950B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2606605T3 (es) 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV
US20140079704A1 (en) * 2012-09-11 2014-03-20 The Texas A&M University System BI-Specific Diabodies For Masking And Targeting Vaccines
CN105949286A (zh) * 2016-07-04 2016-09-21 中国兽医药品监察所 牛病毒性腹泻病毒i型e2蛋白的表达及应用
CN108456663B (zh) * 2018-03-26 2021-09-21 中国农业科学院兰州兽医研究所 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用
CN108614121B (zh) * 2018-05-04 2020-11-20 山东师范大学 牛病毒性腹泻病毒e2蛋白抗原多表位融合肽及其制备与应用
CN111533813B (zh) * 2020-07-09 2020-10-16 苏州世诺生物技术有限公司 牛病毒性腹泻病毒重组亚单位疫苗
CN113403256B (zh) * 2021-06-16 2023-04-18 中国农业科学院特产研究所 一种稳定产生牛病毒性腹泻病毒抗原的细胞系及抗体胶体金检测试纸条的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001613A (en) 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US6168942B1 (en) 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
US6974575B2 (en) * 2001-08-28 2005-12-13 Pfizer Inc. Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
DE10143813A1 (de) 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon
US20080260778A1 (en) * 2004-03-17 2008-10-23 Ellsworth Michael A Method of Vaccination Against Testicular Bvdv Infection
DE102004025452A1 (de) * 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
CA2744750C (en) * 2008-12-03 2018-10-09 Pfizer Inc. Bovine viral diarrhea virus with a modified erns protein
ES2606605T3 (es) 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV

Also Published As

Publication number Publication date
RU2013118351A (ru) 2014-10-27
AU2011306957C1 (en) 2014-08-28
CN103338785A (zh) 2013-10-02
AU2011306957A1 (en) 2013-04-11
US9878030B2 (en) 2018-01-30
WO2012038454A1 (en) 2012-03-29
CA2811243A1 (en) 2012-03-29
EP2618841A1 (en) 2013-07-31
ZA201301950B (en) 2014-03-26
BR112013006515A2 (pt) 2016-08-02
MX2013003245A (es) 2013-05-22
EP2618841B1 (en) 2016-10-19
AU2011306957B2 (en) 2014-07-24
BR112013006515B1 (pt) 2020-04-28
CA2811243C (en) 2019-03-05
CN103338785B (zh) 2015-01-14
RU2578943C2 (ru) 2016-03-27
US20130195892A1 (en) 2013-08-01
ES2606605T3 (es) 2017-03-24

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX2013003245A (es) Vacuna contra virus de diarrea viral de bovinos.
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MY182771A (en) Viral replication inhibitors
MX2018013782A (es) Antigenos y vacunas dirigidos contra enterovirus humanos.
UA110473C2 (uk) Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12015502230A1 (en) Novel viral replication inhibitors
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX2013013801A (es) Oligodesoxinucleotidos inmunoestimuladores.
MX2013013800A (es) Oligodesoxinucleotidos inmunoestimuladores.
EA201290956A1 (ru) Вакцина против вич
WO2013006569A3 (en) Herpes virus vaccine and methods of use
EA201401352A1 (ru) Вакцина против вируса шмалленберга (sbv), способы ее получения и применения
MX350718B (es) Vacuna de rinitis equina.
EA201390452A1 (ru) Вакцина
WO2013093629A3 (en) Modular vaccines, methods and compositions related thereto
PH12019501907A1 (en) Novel viral replication inhibitors
MX2014005499A (es) Combinacion terapeutica de memantina y baclofeno y composicion farmaceutica que los contiene.
UA90646C2 (ru) Способ лечения часто рецидивирующей хронической герпетической инфекции, вызванной вирусом герпеса простого и и ии типов

Legal Events

Date Code Title Description
FG Grant or registration